ANAHEIM, Calif. -- Adding leukotriene receptor antagonists (LTRAs) to antihistamines appears to reduce the severity of chronic urticaria, according to a systematic review and meta-analysis of ...
Please provide your email address to receive an email when new articles are posted on . The addition of leukotriene receptor antagonists to antihistamines improved urticaria symptoms. The combination ...
Since moving from Canada, it seems as if every patient I see in the ER with any type of chronic obstructive pulmonary disease (COPD) -- either bronchitis or emphysema -- has been taking either ...
Use of leukotriene-receptor antagonists (LTRAs) during pregnancy was not associated with significant risks of neuropsychiatric events in offspring, according to a nationwide cohort study from Taiwan.
Biogen Inc. has disclosed uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists with improved brain penetration reported to be useful for the treatment of multiple sclerosis.
A nationwide cohort study conducted in South Korea revealed that bariatric surgery can have a significant impact on the control of disease in obese patients with chronic urticaria, reducing ...
Use of a leukotriene receptor antagonist (LTRA) for asthma management did not increase the risk of neuropsychiatric disease, based on data from more than 60,000 asthma patients. Although LTRAs are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results